AMENDMENT NO. 1
TO
COLLABORATIVE RESEARCH AGREEMENT
BETWEEN GILEAD SCIENCES, INC.
AND
GLAXO WELLCOME INC.
DATED DECEMBER 22, 1997
This Amendment No. 1 (the "Amendment") to the Collaborative Research
Agreement entered into as of the 25th day of March, 1996, (the "Original
Agreement"), is made by and between GILEAD SCIENCES, INC., a Delaware
corporation, having its principal place of business at 000 Xxxxxxxx Xxxxx,
Xxxxxx Xxxx, Xxxxxxxxxx, 00000 ("Gilead") and GLAXO WELLCOME INC., a North
Carolina corporation, having offices at Five Xxxxx Drive, Research Xxxxxxxx
Xxxx, Xxxxx Xxxxxxxx 00000 ("Glaxo"), effective as of December 22, 1997.
WHEREAS, the Parties desire to amend the Original Agreement regarding Section
13.4 "Termination of Research Term by Glaxo."
NOW, THEREFORE, in consideration of the foregoing premises and of the mutual
promises and covenants set forth below, for other good and valuable
consideration the receipt and sufficiency of which the Parties acknowledge,
and in accordance with Article 16.7 of the Original Agreement allowing
modifications by written agreements duly signed by persons authorized to sign
on behalf of the Parties, the Parties, intending to be legally bound, agree
as follows:
1. Unless otherwise defined in this Amendment, the capitalized terms used in
this Amendment shall have the same meaning as given them in the Original
Agreement.
2. Article 13.4 shall be amended by deleting the first sentence of Article
13.4 in its entirety and the following new first sentence of Article 13.4
shall be inserted in lieu thereof:
"Glaxo shall have the right to terminate the Research term prior to
expiration hereunder upon written notice to Gilead; provided, however,
that such termination be effective on the later of (a) June 22, 1998, or
(b) the date notice of termination pursuant to this Article 13.4 is given
to Gilead."
3. Except as modified above, the Original Agreement shall remain in full
force and effect, including, but not limited to, the unamended provisions of
Article 13.4.
IN WITNESS WHEREOF, the Parties have executed this Agreement, as of the day
and year first above written.
GILEAD SCIENCES, INC. GLAXO WELLCOME INC.
By: /s/ Xxxx X. Xxxxxx By: /s/ Xxxxxx X. Xxxx
------------------------ ------------------------
Name: Xxxx X. Xxxxxx Name: Xxxxxx X. Xxxx, Ph.D.
------------------------ ------------------------
Title: CEO Title: Vice President, Research
Glaxo Wellcome Inc.
------------------------ ------------------------
-2-
